Introduction Semaglutide has emerged as a groundbreaking medication in the treatment of type 2 diabetes and obesity, with its ability to address multiple health issues through a single solution. Initially developed as a therapy for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonists, a class of drugs that https://dnatestingservicesinindia64197.wikiconversation.com/6874495/semaglutide_a_revolutionary_treatment_for_diabetes_obesity_and_cardiovascular_health